KPG-818 Myeloma Trials

KPG-818 is a novel small molecule modulator of the CRBN E3 ubiquitin ligase complex CRL4-CRBN.

SparkCures ID	377
Developed By	Kangpu Biopharmaceuticals, Ltd.
Generic Name	KPG-818
Treatment Classifications	Cereblon E3 Ligase Modulators (CELMoDs)

All Clinical Trials

View all active clinical trials around the US.

Verified

KPG-818

View Trial

SparkCures Verified Accurate, up-to-date information. Learn more

Late Relapse Multiple Myeloma

The following is a listing of clinical trials for patients with multiple myeloma who have received three or more prior lines of therapy.

Verified

KPG-818

View Trial

SparkCures Verified Accurate, up-to-date information. Learn more

Smoldering Myeloma

No active clinical trials

Monoclonal Gammopathy of Undetermined Significance (MGUS)

No active clinical trials

KPG-818